Cécile Dupont joined Sofinnova MD Start in 2019. She is currently CEO of HEPTA Medical. Prior to that, she was Director of Clinical, Regulatory and Market Access of SafeHeal, the first company created by MD Start II, where she managed the First-in-Human study execution and regulatory approvals in the EU and US. Prior to joining MD Start, Cécile held various clinical, marketing and regulatory positions in both mature and start-up medical device organizations in the fields of endoscopy, pulmonology, dermatology, surgery and diabetes care; for single and multi-use disposable products and capital equipment. Cécile holds a bachelor’s degree in biomedical engineering from UTC (Université de Technologies de Compiègne) in France and Favoloro University (Buenos Aires) in Argentina.